Impact and clinical significance of recurrent venous thromboembolism

The British Journal of Surgery
N LabropoulosM Meissner

Abstract

The purpose of this review was to analyse current knowledge and controversies associated with the diagnosis, treatment and prevention of recurrent venous thromboembolism (VTE). MEDLINE and manual searches were performed to select prospective papers on the diagnosis, treatment and prevention of recurrent VTE for their relevance and quality. The cumulative incidence of recurrent VTE increases from 11 per cent at 1 year to 40 per cent at 10 years. The incidence of recurrence is higher in unprovoked thrombosis compared with provoked VTE. Patients with unprovoked deep vein thrombosis also have a greater number of multiple recurrences. Ultrasonography or D-dimer monitoring may have an impact on the duration of anticoagulation but further refinements are needed. The incidence of skin damage is higher in ipsilateral recurrence compared with contralateral or no recurrence. Legs with ipsilateral recurrence more often have both reflux and obstruction. The role and weight of the predictive factors for recurrent VTE and its sequelae, and the type and optimal duration of anticoagulation have not been studied adequately. Fatality associated with pulmonary embolism and rates of recurrent VTE remain unacceptably high.

References

May 22, 1995·Archives of Internal Medicine·R J BeythC S Landefeld
Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
Jul 1, 1997·The American Journal of Medicine·J H ArnstenD E Singer
Mar 29, 2000·Archives of Internal Medicine·P O HanssonH Eriksson
Jan 5, 2002·Emergency Medicine Clinics of North America·C L Rosen, J A Tracy
Jan 17, 2002·The New England Journal of Medicine·P F FedulloL J Rubin
Jun 1, 2002·Archives of Internal Medicine·John A HeitL Joseph Melton
Aug 10, 2002·Journal of Vascular Surgery·Astrid M FinkAndreas Steiner
Dec 18, 2002·Annals of Internal Medicine·Paolo PrandoniAntonio Girolami
Jun 20, 2003·Circulation·Richard H White
Jul 2, 2003·Annals of Internal Medicine·Giancarlo AgnelliUNKNOWN Warfarin Optimal Duration Italian Trial Investigators
Jan 14, 2004·Archives of Internal Medicine·Susan R Kahn, Jeffrey S Ginsberg
May 28, 2004·The New England Journal of Medicine·Vittorio PengoUNKNOWN Thromboembolic Pulmonary Hypertension Study Group
Sep 15, 2004·Archives of Internal Medicine·Lori-Ann LinkinsClive Kearon
Jan 27, 2005·Journal of Thrombosis and Haemostasis : JTH·P PrandoniA Girolami
Mar 1, 2005·Journal of Thrombosis and Haemostasis : JTH·S R KahnUNKNOWN Extended Low-intensity Anticoagulation for Thrombo-embolism (ELATE) Investigators
May 5, 2005·Journal of Thrombosis and Haemostasis : JTH·C J J van DongenB A Hutten
May 19, 2005·JAMA : the Journal of the American Medical Association·Sverre C ChristiansenFrits R Rosendaal
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Nov 4, 2005·The New England Journal of Medicine·Ronald J Campbell
Nov 19, 2005·Pathophysiology of Haemostasis and Thrombosis·María-José García-FusterLuis Maldonado
Mar 21, 2006·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A D GiannoukasJ A Michaels
Apr 26, 2006·Circulation·Marius M HoeperLewis J Rubin
Jun 2, 2006·The New England Journal of Medicine·Paul D SteinUNKNOWN PIOPED II Investigators
Oct 27, 2006·The New England Journal of Medicine·Gualtiero PalaretiUNKNOWN PROLONG Investigators
Dec 16, 2006·Seminars in Thrombosis and Hemostasis·Franco PiovellaVictor F Tapson
Mar 21, 2007·Journal of Thrombosis and Haemostasis : JTH·I A NaessJ Hammerstrøm

❮ Previous
Next ❯

Citations

Dec 14, 2011·Hematology·Suresh Vedantham
Dec 14, 2011·Case Reports in Medicine·Kjartan Eskjaer HannigErik Lerkevang Grove
Dec 24, 2013·Thrombosis Research·Ashfaque A MemonKristina Sundquist
Feb 15, 2012·Phlebology·R D Malgor, A P Gasparis
Jan 30, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Julian P CascianoRonald Preblick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
D D RibeiroS M Rezende
Arteriosclerosis, Thrombosis, and Vascular Biology
Tienan ZhuJoseph Emmerich
© 2021 Meta ULC. All rights reserved